FDA Warns of Fake Avastin
WASHINGTON (MedPage Today) — The FDA has alerted healthcare professionals that foreign sellers are marketing an inactive, counterfeit version of bevacizumab, approved in the U.S. under the brand name Avastin.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com